Anhui Huaheng Biotechnology Co., Ltd. announced a private placement of A shares for gross proceeds of not more than CNY 1,727,070,900 on October 27, 2022. The transaction has been approved in the 19th meeting of the 3rd directorate and the 13th meeting of the 3rd supervisory board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
76.39 CNY | -3.95% | -9.50% | -39.32% |
22/04 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
22/04 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.32% | 165.08Cr | |
-9.17% | 2.63TCr | |
+7.92% | 1.1TCr | |
+13.57% | 520.18Cr | |
+4.92% | 393.36Cr | |
-20.61% | 329.66Cr | |
-9.26% | 297.88Cr | |
+28.76% | 276.42Cr | |
-19.25% | 238.79Cr | |
-17.75% | 188.1Cr |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Anhui Huaheng Biotechnology Co., Ltd. announced that it expects to receive CNY 1.7270709 billion in funding